Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Thrombus Aspiration during Primary PCI Does Not Improve Clinical Outcomes

Thrombus Aspiration during Primary PCIThrombus aspiration during primary PCI in ST elevation MI has been extensively used; however, recent studies have questioned its efficacy and safety.

 

This meta-analysis looked into individual patient data to determine the benefit and safety of thrombus aspiration during primary PCI.

 

It included all randomized and controlled studies assessing manual thrombectomy vs. conventional primary PCI including more than 1.000 patients undergoing ST elevation MI. Individual patient data was provided by the lead researchers of each study.

 

Efficacy primary end point was cardiovascular mortality at 30 days and safety primary end point was any stroke or transient ischemic attack also at 30 days.

 

The 3 eligible studies (TAPAS, TASTE and TOTAL) enrolled 18,306 patients receiving primary PCI with available data.

 

Cardiovascular death at 30 days occurred in 221 patients (2.4%) out of 9,155 randomized to thrombectomy and in 262 (2.9%) of those randomized to primary PCI alone (HR: 0.84; CI 95%; p=0.06).

 

Stroke and transient ischemic attack occurred in 66 patients (0.8%) among those randomized to manual thrombectomy compared to 46 (0.5%) in the group of primary PCI alone (OR: 1.43 IC 0.98-2.1; p=0.06).

 

There were no significant differences in repeat MI rate, stent thrombosis, cardiac failure, or target vessel revascularization.

 

When studying the subgroup with high thrombotic load separately, thrombus aspiration was associated to lower cardiovascular death (2.5% vs. 3.1%, HR 0.80; p=0.03) but higher stroke or transient ischemic attack (0.9% vs. 0.5%, p=0.04). Despite these rates, the interaction p value was 0.32 and 0.34, respectively.

 

Conclusion

Routine thrombus aspiration during primary PCI does not improve clinical outcomes. In the subgroup of patients with high thrombotic load, there was a tendency to lower mortality and higher stroke rates, which provides the rationale for future studies.

 

Editorial Comment

The AHA/ACC 2015 guidelines state the use of thrombus aspiration in the context of primary PCI is IIb/C for cases with intra-luminal thrombus, and class III for routine use, in all cases. 

 

To date, the existing literature does not support the routine use of thrombus aspiration in the management of ST elevation acute myocardial infarction. Operators might consider the benefit of this technique is potentially higher than its risks on a case by case basis.

 

Original Title: Thrombus Aspiration in ST Elevation Myocardial Infarction: An Individual Patient Meta-analysis.

Reference: Sanjit S. Jolly et al. Circulation 2016 Dec 9. [Epub ahead of print].


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...